| Application no. and date | 14200334.2 (espacenet) (Federated) (European Patent Register), 20110909 | | Patent/reg. no. and date | DK/EP 2977057, 20191106 | | Publication date | 20160127 | | Priority no. and date | US 403011 P, 20100909, US 456014 P, 20101029, US 201161432372 P, 20110113, WO PCT/US2011/033699, 20110423 | | EP pub. no. and date |
EP 2977057 20160127 | | Effective date | | | Applicant/owner | Alexion Pharmaceuticals, Inc., 121 Seaport Boulevard
Boston, MA 02210, US | | Applicant ref. no. | P81500984DK01E | | Inventor | Quinn, Anthony, 107 Manet Road
Chestnut Hill, MA Massachusetts 02467, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/135 (2006.01) , A61K 31/366 (2006.01) , A61K 31/397 (2006.01) , A61K 31/465 (2006.01) , A61K 38/46 (2006.01) , A61P 3/06 (2006.01) , C12N 9/18 (2006.01) | | Title | Isoleret rekombinant human N-glycosyleret lysosomal syrelipase | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
